Prothena Corporation plc (PRTA)
After hours:
Chart Events
Performance Outlook
| Previous Close | 26.77 |
| Open | 26.53 |
| Bid | 26.80 x 800 |
| Ask | 42.83 x 900 |
| Day's Range | 25.59 - 27.04 |
| 52 Week Range | 21.06 - 79.75 |
| Volume | |
| Avg. Volume | 433,903 |
| Market Cap | 1.255B |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | 19.95 |
| EPS (TTM) | 1.34 |
| Earnings Date | May 05, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.88 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PRTA
Related Research
- Prothena Corporation plcWeekly Stock ListStocks have struggled in 2Q 2022, with the S&P 500 on its way to a double-digit drop for the period. Absent the rally in recent days, the decline would be closer to 20%. Growth stocks have again been the weakest performers, as sectors such as Technology, Communication Services, and Consumer Discretionary all have lagged the major market indices. The leading sectors were value-oriented, including Energy, Consumer Staples, Basic Materials, and Utilities. The average stock in the Argus Universe of Coverage has declined 13.1% thus far during the quarter, and the median stock declined 12.5%. The average BUY-rated stock dropped 12.6%, while the average HOLD-rated stock fell 14.4%. Will investors continue to favor value in 2022? Will high inflation drive continued outperformance in Energy and Basic Materials? Given interest rates that remain historically low, we expect growth stocks to resume outperformance over time, and think 2022 may be a "one-in-five year" that value leads. Investors seeking value are encouraged to focus on dividends and look for yields in the 3%-4% range. Concerning sectors, our current Over-Weights are Energy, Financial, Healthcare, Industrials, and Basic Materials. Here are the top-10 and bottom-five performers from the Argus Universe in 2Q.RatingFair ValueEconomic Moat2 days agoArgus Research
- Simply Wall St.
Prothena Corporation plc's (NASDAQ:PRTA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 30% over the past three months, it is easy to disregard Prothena (NASDAQ:PRTA). However, a closer...
- Zacks
Why Is Epizyme (EPZM) Up 51.7% Since Last Earnings Report?
Epizyme (EPZM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire
Prothena to Participate in Jefferies Healthcare Conference
DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday June 8, 2022 at 8:30 AM ET. A live webcast of the fireside chat can be accessed through the investor relations section of
